Rubén M Muñoz

The mitotic serine threonine kinase, Aurora-2, is a potential target for drug development in human pancreatic cancer.

Haiyong Han, D. V. Von Hoff, R. Nagle, 2004, Molecular cancer therapeutics.

The cationic porphyrin TMPyP4 down-regulates c-MYC and human telomerase reverse transcriptase expression and inhibits tumor growth in vivo.

Haiyong Han, D. V. Von Hoff, D. Bearss, 2002, Molecular cancer therapeutics.